FDA tentatively OKs Perrigo's Sernivo Spray 0.05%

Apr. 04, 2019 8:55 AM ETPerrigo Company plc (PRGO)By: Mamta Mayani, SA News Editor
  • The FDA tentatively approves Perrigo's (NYSE:PRGO) generic version of Sernivo (betamethasone dipropionate) Spray 0.05%. Perrigo previously settled its Sernivo patent dispute with Promius Pharma.
  • Tentative approval means that the application met the requirements for safety and efficacy but patent issues need to be resolved.
  • Per IQVIA, market sales for year ended February 2019 were ~$15M.
  • Previously: Perrigo settles Sernivo patent dispute with Promius (Nov. 28, 2018)

Recommended For You


To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.